Lightbridge's biggest risks in the FY2024 10-K
- Lightbridge relies heavily on US government funding and faces significant capital needs with $40.0 million in cash against a $164.2 million accumulated deficit.
- Commercializing its nuclear fuel depends heavily on test reactors, national laboratory resources, and overcoming unproven commercial reactor performance.
- The company faces supply chain vulnerabilities for HALEU and other materials, alongside potential dilution from proposed share increases.
The risks most specific to Lightbridge
- Risks Related to Our Business
We will need to raise significant additional capital in the future to expand our operations and continue our R&D activities and we may be unable to raise such funds when needed on acceptable terms, or at all. Any capital raises may cause significant dilution to our shareholders
As of December 31, 2024, we had $40.0 million in cash and an accumulated deficit of $164.2 million, requiring significant future capital raises that will dilute shareholders.
- Risks Related to Our Business
We are dependent upon significant U.S. government funding and/or in-kind contributions and political support for nuclear power in order to complete our fuel development efforts and commercialize our nuclear fuel technology
Our fuel development timeline depends heavily on significant funding and in-kind contributions from the U.S. government.
- Risks Related to Our Business
Development of our nuclear fuel technology is dependent upon the availability of a test reactor and access to adequate resources and manufacturing capabilities at national laboratories
Further testing of our fuel designs at the Halden research reactor in Norway is impossible because the facility permanently shut down in June 2018.
- Risks Related to Our Business
Our fuel designs have never been tested in an existing commercial reactor and actual fuel performance, as well as the willingness of commercial reactor operators and fuel fabricators to adopt a new design, is uncertain
Our metallic nuclear fuel designs have never been tested in an existing commercial reactor, creating uncertainty regarding performance and operator adoption.
- Risks Related to Our Business
The cost of production of our nuclear fuel could be prohibitively expensive
Production costs for our nuclear fuel are estimated at $5,000 to $10,000 per kilogram, which could prove prohibitively expensive.
- Risks Related to Our Business
We rely on a limited number of suppliers for HALEU or other key source materials and/or key components and/or key equipment necessary for the development and fabrication of our nuclear fuel, which could, under certain circumstances, adversely delay our research and development activities
We rely on a limited number of suppliers for HALEU and key components, risking severe delays to our research and development activities.
- Risks Related to Our Business
Applicable Russian intellectual property law may not protect some of our intellectual property, which could have a material adverse effect on our business
Evolving Russian intellectual property laws and our reliance on Russian contractors and employees to develop early material IP may not adequately protect our assets.
- Risks Related to the Ownership of Our Common Stock
The Company currently has a limited number of authorized common shares available for future issuance
We have only 3.1 million authorized unissued common shares available, prompting a shareholder vote to increase authorized common stock from 25 million to 100 million shares.
- Risks Related to the Ownership of Our Common Stock
Our ability to utilize our net operating loss carryforwards to offset future taxable income will be limited and may also expire
Our ability to use net operating loss carryforwards to offset future taxable income is limited by past and future ownership changes under Section 382.
All 31 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Business
- 01We will need to raise significant additional capital in the future to expand our operations and continue our R&D activities and we may be unable to raise such funds when needed on acceptable terms, or at all. Any capital raises may cause significant dilution to our shareholders
- 02We are dependent upon significant U.S. government funding and/or in-kind contributions and political support for nuclear power in order to complete our fuel development efforts and commercialize our nuclear fuel technology
- 03The amount of time and funding needed to bring our nuclear fuel to market may greatly exceed our projections
- 04Our current economic model for selling our nuclear fuel may prove to be inaccurate and subject to competition and our nuclear fuel technology products may not be cost effective
- 05Development of our nuclear fuel technology is dependent upon the availability of a test reactor and access to adequate resources and manufacturing capabilities at national laboratories
- 06Our fuel designs have never been tested in an existing commercial reactor and actual fuel performance, as well as the willingness of commercial reactor operators and fuel fabricators to adopt a new design, is uncertain
- 07If our fuel designs do not perform as anticipated in commercial reactor conditions, we will not realize revenues from licensing or other use of our fuel designs
- 08The cost of production of our nuclear fuel could be prohibitively expensive
- 09Successful execution of our business model is dependent upon public support for nuclear power and overcoming public opposition to nuclear energy
- 10We rely on a limited number of suppliers for HALEU or other key source materials and/or key components and/or key equipment necessary for the development and fabrication of our nuclear fuel, which could, under certain circumstances, adversely delay our research and development activities
- 11Labor shortages and supply chain disruptions could prevent us from meeting our R&D timelines and have a negative impact on our financial results
- 12If the price of non-nuclear energy sources falls, whether as the result of government policy or otherwise, there could be an adverse impact on nuclear energy, which would have a material adverse effect on our operations
- 13We are dependent on management and key personnel for our success, and the loss of which could have a material adverse effect on our business
- 14The loss of the services of qualified employees and any inability to recruit effective replacements or to otherwise attract, motivate, train, or retain highly qualified and diverse employees could have a material adverse effect on our business, financial condition, and results of operations
- 15We may not be able to receive or retain authorizations that may be required for us to sell or license our technology internationally
- 16Potential competitors could limit opportunities to license our technology
- 17If we infringe or are alleged to infringe intellectual property rights of third-parties, our business, financial condition, and results of operations could be adversely affected
- 18Technological changes could render our technology and products uncompetitive or obsolete, which could prevent us from achieving market share and sales
- 19We may acquire other companies or technologies, which could divert our managements’ attention, result in dilution to our stockholders and otherwise disrupt our operations and adversely affect our operating results
- 20the use of substantial portions of our available cash to consummate the acquisition
- 21If we are unable to obtain or maintain intellectual property rights and trade secrets relating to our technology, the commercial value of our technology may be adversely affected, which could in turn adversely affect our business, financial condition, and results of operations
- 22Applicable Russian intellectual property law may not protect some of our intellectual property, which could have a material adverse effect on our business
- 23Material weaknesses in our internal control over financial reporting may be identified, which could adversely affect our ability to provide accurate and timely financial statements and harm investor confidence
- 24potential enforcement actions or penalties
Risks Related to the Ownership of Our Common Stock
- 25The issuance of additional stock in connection with financings, acquisitions, investments, our stock incentive plans or otherwise will dilute all other stockholders
- 26The Company currently has a limited number of authorized common shares available for future issuance
- 27We may issue preferred stock with rights senior to our common stock
- 28There may be volatility in our stock price, which could negatively affect investments, and our stockholders may not be able to resell their shares at or above the value they originally purchased such shares
- 29the risks discussed elsewhere in this Annual Report on Form 10-K
- 30Our ability to utilize our net operating loss carryforwards to offset future taxable income will be limited and may also expire
- 31Shareholder activism could cause us to incur significant expense, hinder execution of our business strategy and impact our stock price
Other Lightbridge 10-Ks
- FY2025 10-K risk factors32 risks4 new3 dropped10 reworded
Lightbridge expanded its authorized common stock from 25 million to 100 million shares and raised cash reserves to $201.9 million.
Filed Feb 26, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.